cannabis indica

Índice completo — página 64 de 77

Estudos 6.301 a 6.400 de 7.640, ordenados do mais recente ao mais antigo — nesta página, publicações de 2011. Para buscar por termo ou combinar filtros, use o acervo com busca.

Estudos 6.301 a 6.400

  1. 2011

    Cannabidiol Protects Against Hepatic Ischemia/Reperfusion Injury by Attenuating Inflammatory Signaling and Response, Oxidative/Nitrative Stress, and Cell Death

    FavorávelEstudo em AnimaisInflamaçãoDoenças Cardiovasculares (DCV)Lesão de Reperfusão
  2. 2011

    Cannabidiol reduces brain damage and improves functional recovery after acute hypoxia-ischemia in newborn pigs

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)Disfunção CognitivaEstresse Oxidativo+2
  3. 2011

    Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients

    FavorávelEnsaio Clínico Duplo-CegoAnsiedade
  4. 2011

    Cannabinoid Administration Attenuates the Progression of Simian Immunodeficiency Virus

    FavorávelEstudo em AnimaisInflamaçãoHIV/AIDSImunodeficiência por Trauma
  5. 2011

    Cannabinoid as a neuroprotective strategy in perinatal hypoxic-ischemic injury

    InconclusivoMetanáliseGestaçãoTrabalho de Parto e Complicações
  6. 2011

    Cannabinoid effects on ventilation and breathlessness: a pilot study of efficacy and safety.

    FavorávelEnsaio Clínico Duplo-CegoDPOCTetraidrocanabinol (THC)
  7. 2011

    Cannabinoid hyperemesis syndrome

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  8. 2011

    Cannabinoid hyperemesis syndrome as the underlying cause of intractable nausea and vomiting

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  9. 2011

    Cannabinoid hyperemesis syndrome inducing acute prerenal failure and electrolyte disturbance

    DesfavorávelMetanáliseSíndrome da Hiperêmese CanabinoideInsuficiência Renal
  10. 2011

    Cannabinoid receptor 2 and its agonists mediate hematopoiesis and hematopoietic stem and progenitor cell mobilization

    FavorávelEstudo em AnimaisRejeição de TransplanteCanabinoides Sintéticos AM-x
  11. 2011

    Cannabinoid receptor antagonists AM251 and AM630 activate TRPA1 in sensory neurons

    FavorávelEstudo LaboratorialCanabinoides Sintéticos AM-x
  12. 2011

    Cannabinoid receptor type 1 protects nigrostriatal dopaminergic neurons against MPTP neurotoxicity by inhibiting microglial activation

  13. 2011

    Cannabinoid Receptor Type I Modulates Alcohol-Induced Liver Fibrosis

  14. 2011

    Cannabinoid type 1 receptor antagonists for smoking cessation

    DesfavorávelMetanálise ClínicaDependência QuímicaDependência — NicotinaCanabinoides Sintéticos SR-x
  15. 2011

    Cannabinoid-induced hyperemesis

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  16. 2011

    Cannabinoid-opioid Interaction In Chronic Pain

    FavorávelEnsaio ClínicoDependência QuímicaDependência — Opioides
  17. 2011

    Cannabinoids and Endocannabinoids in Metabolic Disorders with Focus on Diabetes

  18. 2011

    Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials.

  19. 2011

    Cannabinoids: Potential Targets for Bladder Dysfunction

    FavorávelMetanáliseInfecção Urinária
  20. 2011

    Cannabis in Palliative Medicine: Improving Care and Reducing Opioid-Related Morbidity

  21. 2011

    Cannabis Use in Patients with Fibromyalgia: Effect on Symptoms Relief and Health-Related Quality of Life

    FavorávelMetanáliseFibromialgia
  22. 2011

    CB1 - cannabinoid receptor antagonist effects on cortisol in cannabis-dependent men

  23. 2011

    Chronic administration of THC prevents the behavioral effects of intermittent adolescent MDMA administration and attenuates MDMA-induced hyperthermia and neurotoxicity in rats

  24. 2011

    Chronic restraint stress impairs endocannabinoid mediated suppression of GABAergic signaling in the hippocampus of adult male rats

    FavorávelEstudo em Animais
  25. 2011

    Chronic spinal cord injury pain: pharmacological and non-pharmacological treatments and treatment effectiveness

    FavorávelMetanáliseDorDor — CrônicaLesões da Medula Espinhal
  26. 2011

    Cognitive Reserve in Aging.

    FavorávelMetanáliseDoença de Alzheimer
  27. 2011

    Comparative anti-infectious bronchitis virus (IBV) activity of (-)-pinene: effect on nucleocapsid (N) protein.

    FavorávelEstudo LaboratorialInfecções Bacterianas
  28. 2011

    Consequences Of Cannabinoid And Monoaminergic System Disruption In A Mouse Model Of Autism Spectrum Disorders

    FavorávelEstudo em AnimaisEsquizofreniaAutismoTetraidrocanabinol (THC)
  29. 2011

    Corticosterone Mediates Reciprocal Changes in CB1 and TRPV1 Receptors in Primary Sensory Neurons in the Chronically Stressed Rat

  30. 2011

    Deletion of cannabinoid receptors 1 and 2 exacerbates APC function to increase inflammation and cellular immunity during influenza infection

    FavorávelEstudo em AnimaisGripe
  31. 2011

    Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial

    FavorávelEnsaio Clínico Duplo-CegoDorCâncerInflamaçãoTHC Farmacêutico+10
  32. 2011

    Developmental consequences of perinatal cannabis exposure: behavioral and neuroendocrine effects in adult rodents

    DesfavorávelMetanáliseTranstornos de Comportamento
  33. 2011

    Does change in cannabis use in established psychosis affect clinical outcome?

    InconclusivoEnsaio ClínicoEfeitos Adversos da CannabisDependência — CannabisPsicose+5
  34. 2011

    Dramatic improvement of refractory Isaacs' syndrome after treatment with dronabinol.

  35. 2011

    Dronabinol, a cannabinoid agonist, reduces hair pulling in trichotillomania: a pilot study.

    FavorávelEnsaio ClínicoTricotilomaniaTHC Farmacêutico
  36. 2011

    Effects of anandamide in migraine: data from an animal model

    FavorávelEstudo em AnimaisEnxaquecaAnandamida (AEA)
  37. 2011

    Effects of cannabinoid CB1 receptor agonism and antagonism on SKF81297-induced dyskinesia and haloperidol-induced dystonia in Cebus apella monkeys

    InconclusivoEstudo em AnimaisDistoniaCanabinoides Sintéticos SR-xCanabinoides Sintéticos CP-x
  38. 2011

    Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.

  39. 2011

    Effects of lipid-lowering therapy with rosuvastatin on kidney function and oxidative stress in patients with diabetic nephropathy

  40. 2011

    Effects of the cannabinoid-1 receptor antagonist rimonabant on psychiatric symptoms in overweight people with schizophrenia: a randomized, double-blind, pilot study

    DesfavorávelEnsaio Clínico Duplo-CegoEsquizofreniaObesidadeTHC Farmacêutico
  41. 2011

    Efficacy and safety of CP-945,598, a selective cannabinoid CB1 receptor antagonist, on weight loss and maintenance

    FavorávelEnsaio Clínico Duplo-CegoDorAnsiedadeNáusea e VômitoCanabinoides Sintéticos CP-x+5
  42. 2011

    Efficacy of monoterpene perillyl alcohol upon survival rate of patients with recurrent glioblastoma.

    FavorávelEnsaio ClínicoCâncerCâncer — Cérebro
  43. 2011

    Endocannabinoid signaling and epidermal differentiation

  44. 2011

    Endocannabinoids and stress

  45. 2011

    Endocannabinoids and traumatic brain injury

  46. 2011

    Endocannabinoids in Liver Disease

  47. 2011

    Evaluation Of The Cyclooxygenase Inhibiting Effects Of Six Major Cannabinoids Isolated From Cannabis Sativa

    FavorávelEstudo LaboratorialCâncerCâncer — CólonTetraidrocanabinol (THC)Canabigerol (CBG)+3
  48. 2011

    Evaluation of the efficiency of tamsulosin and Rowatinex in patients with distal ureteral stones: a prospective, randomized, controlled study

    InconclusivoEnsaio Clínico Duplo-CegoCálculos Renais
  49. 2011

    Fish oil promotes survival and protects against cognitive decline in severely undernourished mice by normalizing satiety signals

  50. 2011

    Fresh, dried or smoked? repellent properties of volatiles emitted from ethnomedicinal plant leaves against malaria and yellow fever vectors in Ethiopia

    FavorávelEstudo em AnimaisMalária
  51. 2011

    Functional polymorphism in the GPR55 gene is associated with anorexia nervosa

    InconclusivoMetanáliseAnorexia (perda de apetite)Anorexia Nervosa
  52. 2011

    Gastroprotective Activity of α-Terpineol in Two Experimental Models of Gastric Ulcer in Rats

    FavorávelEstudo em AnimaisÚlcera Gástrica
  53. 2011

    Heart fatty acid-binding protein offers similar diagnostic performance to high-sensitivity troponin T in emergency room patients presenting with chest pain

  54. 2011

    Heart-type fatty acid binding protein and the diagnosis of acute coronary syndrome in the ED

  55. 2011

    Homeostatic changes of the endocannabinoid system in Parkinson's disease

    FavorávelMetanáliseDoença de Parkinson
  56. 2011

    Hyperemesis and a high water bill

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  57. 2011

    Impact of cannabis use on male sexual health

    InconclusivoMetanáliseLibidoDisfunção Erétil
  58. 2011

    Increased blood pressure after abrupt cessation of daily cannabis use

  59. 2011

    Increased Expression of Cannabinoid CB1 Receptors in Achilles Tendinosis

    FavorávelEstudo LaboratorialTendinopatias
  60. 2011

    Influence of Cannabis Use on Severity of Hepatitis C Disease.

    DesfavorávelMetanáliseFibroseHepatiteFibrose — Hepática (Cirrose)
  61. 2011

    Inhibitory CB1 and activating/desensitizing TRPV1-mediated cannabinoid actions on CGRP release in rodent skin.

    FavorávelEstudo em AnimaisDorAnandamida (AEA)Tetraidrocanabinol (THC)+1
  62. 2011

    Inhibitory effect of standardized cannabis sativa extract and its ingredient cannabidiol on rat and human bladder contractility

    InconclusivoEstudo LaboratorialInfecção Urinária
  63. 2011

    Involvement of the endocannabinoid system in reward processing in the human brain

  64. 2011

    Involvement of the Endocannabinoid System in the Neurobehavioral Effects of Stress and Glucocorticoids.

    FavorávelMetanáliseAnandamida (AEA)2-Araquidonoilglicerol (2-AG)
  65. 2011

    Is There a Legitimate Role for the Therapeutic Use of Cannabinoids for Symptom Management in Chronic Kidney Disease?

  66. 2011

    Limonene, a natural cyclic terpene, is an agonistic ligand for adenosine A(2A) receptors.

    FavorávelEstudo LaboratorialDorDor — Polineuropatia InflamatóriaAcne
  67. 2011

    Local Application Of The Endocannabinoid Hydrolysis Inhibitor URB597 Reduces Nociception In Spontaneous And Chemically Induced Models Of Osteoarthritis

  68. 2011

    Loss Of Striatal Cannabinoid CB1 Receptor Function In Attention-deficit / hyperactivity Disorder Mice With Point-mutation Of The Dopamine Transporter

    FavorávelEstudo em AnimaisTDA e TDAH
  69. 2011

    Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease.

    FavorávelEstudo em AnimaisDoença de Huntington
  70. 2011

    Low-volume Binary Drug Therapy for the Treatment of Hypovolemia

    FavorávelEstudo em AnimaisChoque Hemorrágico
  71. 2011

    Marijuana use and testicular germ cell tumors

    DesfavorávelMetanáliseCâncerCâncer — Testículo
  72. 2011

    Marijuana Use is Not Associated with Cervical Human Papillomavirus Natural History or Cervical Neoplasia in HIV-seropositive or HIV-seronegative Women

    InconclusivoMetanáliseCâncerCâncer — Colo do Útero
  73. 2011

    MDMA & Cannabis: A Mini-Review of Cognitive, Behavioral, and Neurobiological Effects of Co-Consumption

    DesfavorávelMetanáliseEfeitos Adversos da CannabisEfeitos Adversos do MDMA
  74. 2011

    Minireview: Recent Developments in the Physiology and Pathology of the Lysophosphatidylinositol-Sensitive Receptor GPR55

  75. 2011

    Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI study

    FavorávelEnsaio Clínico Duplo-CegoAnsiedadeDisfunção CognitivaPsicoseTetraidrocanabinol (THC)
  76. 2011

    Modulation of Inflammatory Responses by a Cannabinoid-2–Selective Agonist after Spinal Cord Injury

    FavorávelEstudo em AnimaisInflamaçãoLesões da Medula EspinhalCanabinoides Sintéticos O-x
  77. 2011

    Molecular allergology in practice: an unusual case of LTP allergy.

    FavorávelMetanáliseInflamaçãoDermatite de Contato Alérgica
  78. 2011

    Myocardial protective effect of human atrial natriuretic Peptide in cardiac surgery. -hANP Shot” in clinical safety trial-

  79. 2011

    Neural Basis Of Anxiolytic Effects Of Cannabidiol (CBD) In Generalized Social Anxiety Disorder: A Preliminary Report

    FavorávelEnsaio Clínico Duplo-CegoAnsiedade
  80. 2011

    Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease.

  81. 2011

    New FAAH inhibitors based on 3-carboxamido-5-aryl-isoxazole scaffold that protect against experimental colitis

  82. 2011

    Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action

    FavorávelEstudo em AnimaisDorDor — NociceptivaAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+3
  83. 2011

    Nonpsychotropic cannabinoids, abnormal cannabidiol and canabigerol-dimethyl heptyl, act at novel cannabinoid receptors to reduce intraocular pressure

  84. 2011

    Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions

  85. 2011

    Obesity and cannabis use: results from 2 representative national surveys.

    FavorávelMetanáliseObesidade
  86. 2011

    Ocular hypotensive effect of oral palmitoyl-ethanolamide: a clinical trial

    FavorávelEnsaio Clínico Duplo-CegoDorInflamaçãoDor — CrônicaAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+6
  87. 2011

    Olmesartan reduces arterial stiffness and serum adipocyte fatty acid-binding protein in hypertensive patients

  88. 2011

    Palmitoylethanolamide effects on intraocular pressure after Nd:YAG laser iridotomy: an experimental clinical study

    FavorávelEnsaio ClínicoDorInflamaçãoGlaucomaPalmitoiletanolamida (PEA)+1
  89. 2011

    Palmitoylethanolamide restores myelinated-fibre function in patients with chemotherapy-induced painful neuropathy

    FavorávelEnsaio Clínico Duplo-CegoDorDor — Neuropatia PeriféricaDor — OncológicaPalmitoiletanolamida (PEA)+1
  90. 2011

    Pathways Mediating The Effects Of Cannabidiol On The Reduction Of Breast Cancer Cell Proliferation, Invasion, And Metastasis

    FavorávelEstudo em AnimaisCâncerCâncer — MamaCâncer — Pulmão
  91. 2011

    Pharmacogenetic trial of a cannabinoid agonist shows reduced fasting colonic motility in patients with nonconstipated irritable bowel syndrome

  92. 2011

    Pharmacokinetics of a Combination of Δ9-tetrahydro-cannabinol and Celecoxib in a Porcine Model of Hemorrhagic Shock

    FavorávelEstudo em AnimaisChoque Hemorrágico
  93. 2011

    Potential benefit of statin therapy for dyslipidemia with chronic kidney disease: Fluvastatin Renal Evaluation Trial (FRET)

  94. 2011

    Prospects for cannabinoid therapies in basal ganglia disorders.

    FavorávelMetanáliseInflamaçãoDoenças NeurodegenerativasDoença de Parkinson+1
  95. 2011

    Recent advances in the understanding of the role of the endocannabinoid system in liver diseases

  96. 2011

    Recruitment of Prefrontal Cortical Endocannabinoid Signaling by Glucocorticoids Contributes to Termination of the Stress Response

    FavorávelEstudo em AnimaisAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+3
  97. 2011

    Renovascular protective effects of erythropoietin in patients with chronic kidney disease

  98. 2011

    Rimonabant for neurocognition in schizophrenia: a 16-week double blind randomized placebo controlled trial

  99. 2011

    Role of sensory nerves in gastroprotective effect of anandamide in rats

    FavorávelEstudo em AnimaisÚlcera GástricaAnandamida (AEA)
  100. 2011

    Salvianic borneol ester reduces β-amyloid oligomers and prevents cytotoxicity

    FavorávelEstudo LaboratorialDoença de Alzheimer